Hadeel Salem Kadhm Al-Marsumi, MD
Endocrinology · Concord
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 16
- 3 carriers
- Office
- 1
- Since medical school
- 19 years
- Graduated 2007
Offices
1 location · Jiva Health Inc · 46 clinicians in this group
Looking this up.
Hospitals listed: Marshall Medical Center. That is not proof they admit you there this week.
Plans that list them
16 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Al-Marsumi’s office at (925) 685-4228 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
16 of 16 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Marshall Medical CenterPlacerville, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Marshall Medical CenterPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Marshall Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 1 better, 8 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.99) · 532 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.46 to 1.26) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 181.35 (122.12 to 240.58) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.7 · 116 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 52 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 245 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 368 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.9 · 171 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.3 · 1,441 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.3 (0.08 to 0.52) · 3,312 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 3,241 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.31 (1.98 to 6.63) · 546 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.32) · 122 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.13 (0.47 to 3.79) · 499 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.5 (0 to 16.61) · 124 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.8 (0.64 to 8.96) · 119 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 135 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.26 (0 to 1.13) · 2,770 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 40 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.56 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.1 · 242 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.9 · 263 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 9.2 · 381 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 384 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.1 (5 to 9.9) · 225 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.5 to 15) · 225 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5 · 43 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.8 (9.1 to 15.1) · 1,577 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 545 cases | No different | Jan 2024 – Dec 2024 |
What patients said (540 patients answered, 21% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Drugs they prescribed that Part D paid
$3,919
Pharmacies billed $3,919 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 24) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
$3,919 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Single Use Swab | 12 | $28 | $2 |
Year by year
| 2024 | 24 | None | 0% (0) | None | $3,919 |
| 2023 | 221 | 39 | 0% (0) | 37% | $184,074 |
| 2022 | 362 | 66 | 0% (0) | 42% | $198,356 |
| 2021 | 371 | 70 | 0% (0) | 29% | $88,766 |
| 2020 | 173 | 37 | 0% (0) | None | $18,847 |
| 2019 | 190 | 49 | None | None | $14,297 |
| 2018 | 55 | 29 | None | None | $1,247 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Ozempic | 12 | $19,361 | $1,613 |
| Basaglar Kwikpen U-100 | 16 | $5,679 | $355 |
| Ultra-Fine Nano Pen Needle | 16 | $1,127 | $70 |
| Nano 2nd Gen Pen Needle | 13 | $812 | $62 |
| Levothyroxine | 22 | $579 | $26 |
| Single Use Swab | 22 | $67 | $3 |
2022: 13 drugs
| Trulicity | 11 | $20,789 | $1,890 |
| Ozempic | 18 | $17,884 | $994 |
| Lantus Solostar | 22 | $14,884 | $677 |
| Novolog Flexpen | 11 | $10,907 | $992 |
| Basaglar Kwikpen U-100 | 19 | $7,685 | $404 |
| Comfort Ez Pen Needle | 22 | $1,807 | $82 |
| Ultra-Fine Short Pen Needle | 14 | $1,217 | $87 |
| Levothyroxine | 39 | $1,005 | $26 |
| Methimazole | 12 | $263 | $22 |
| Metformin Hcl Er | 13 | $221 | $17 |
| Alendronate | 12 | $158 | $13 |
| Single Use Swab | 19 | $50 | $3 |
| Easy Touch Alcohol Prep Pads | 11 | $46 | $4 |
2021: 7 drugs
| Levothyroxine | 15 | $318 | $21 |
| Losartan | 21 | $294 | $14 |
| Atorvastatin | 13 | $249 | $19 |
| Metformin | 16 | $228 | $14 |
| Hydrochlorothiazide | 12 | $169 | $14 |
| Metoprolol | 14 | $114 | $8 |
| Furosemide | 12 | $109 | $9 |
2020: 1 drug
| Pantoprazole | 11 | $88 | $8 |
2019: 4 drugs
| Chlorthalidone | 13 | $359 | $28 |
| Gabapentin | 13 | $165 | $13 |
| Amlodipine Besylate | 15 | $45 | $3 |
| Furosemide | 11 | $35 | $3 |
Money from drug and device companies
$221 in 2025
| 2025 | 4 | 5 | None | $221 |
| 2024 | 1 | 1 | None | $150 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Sanofi-Aventis U.S. | Tzield | $122 | 1 payment
|
| Medtronic | Minimed 780g | $50 | 2 payments
|
| Novo Nordisk | Rybelsus | $26 | 1 payment
|
| Xeris Pharmaceuticals | Recorlev | $24 | 1 payment
|
See all 5 published payments
| Medtronic | Meals · 2025-12-30 | Minimed 780g | $18 |
| Xeris Pharmaceuticals | Meals · 2025-12-02 | Recorlev | $24 |
| Novo Nordisk | Meals · 2025-10-27 | Rybelsus | $26 |
| Sanofi-Aventis U.S. | Meals · 2025-09-18 | Tzield | $122 |
| Medtronic | Meals · 2025-09-11 | Minimed 780g | $32 |
See earlier years (2024)
2024: $150
| Insulet | Omnipod | $150 | 1 payment
|
Professional record
- NPI
- 1285130096
- Group
- Jiva Health Inc
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RE0101X (207RE0101X); Student in a training program (390200000X)
- Mailing address
- 2182 East St, Concord, CA, 94520
- NPI first listed
- 2018-04-02
- NPI last updated
- 2025-06-14
- NPI record certified
- 2025-06-14
This is when the NPI record was last certified, not a medical board exam.